Berkshire Hathaway stock: OxyChem deal closes as investors size up the Abel era
Berkshire Hathaway completed its $9.7 billion all-cash acquisition of Occidental Petroleum’s OxyChem unit on Friday. Berkshire’s Class B shares fell 1.15% to $496.85, underperforming the broader market. The deal expands Berkshire’s chemicals business and comes as investors watch for further capital moves after Warren Buffett’s leadership transition. OxyChem’s final price remains subject to post-closing adjustments.